Avoro Capital Advisors LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 132 filers reported holding TG THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
Avoro Capital Advisors LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$7,872,000
-29.1%
800,000
-20.0%
0.27%
-18.4%
Q4 2019$11,100,000
-43.0%
1,000,000
-78.9%
0.33%
-72.0%
Q4 2018$19,475,000
-17.2%
4,750,000
+13.1%
1.16%
+7.8%
Q3 2018$23,520,000
-63.9%
4,200,031
-15.2%
1.08%
-56.9%
Q2 2018$65,093,000
-12.3%
4,950,031
-5.3%
2.51%
-29.3%
Q1 2018$74,261,000
+174.9%
5,229,619
+58.7%
3.55%
+102.5%
Q4 2017$27,015,0003,294,4631.75%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
M28 Capital Management LP 726,200$3,086,0003.46%
Paradigm Biocapital Advisors LP 1,964,709$8,350,0001.66%
683 Capital Management, LLC 3,300,000$14,025,0000.99%
MAVERICK CAPITAL LTD 6,747,549$28,677,0000.71%
Antara Capital LP 1,500,000$6,375,0000.27%
Parkwood LLC 47,168$1,375,0000.24%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,677,500$11,379,0000.24%
PURA VIDA INVESTMENTS, LLC 950,813$4,041,0000.24%
OCCUDO QUANTITATIVE STRATEGIES LP 567,576$2,412,0000.20%
Antara Capital LP 900,000$3,825,0000.16%
View complete list of TG THERAPEUTICS INC shareholders